RZLT

Rezolute Inc.

Price

$4.72

return (12m)

-27.05%

p/e

-5.87

p/bv

4.09

DIVIDEND YIELD

0.00%

RZLT price

Rezolute

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RZLT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.71%

3 months

41.32%

1 year

-27.05%

2 years

10.28%

5 years

-52.80%

10 years

-90.27%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals RZLT

Valuation

P/E

-5.87

Sector -4.38

Industry -4.38

P/BV

4.09

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-20.63

Sector -263.09

Industry -263.09

EV/EBIT

-20.62

Sector -702.90

Industry -702.90

P/EBITDA

-5.48

Sector -4.39

Industry -4.39

P/EBIT

-5.48

Sector -4.73

Industry -4.73

P/Total Assets

3.81

Sector 1.49

Industry 1.49

P/Net Current Assets

4.22

Sector -11.70

Industry -11.70

P/Working Capital

4.18

Sector -3.19

Industry -3.19

EPS

-0.78

Sector -2.14

Industry -2.14

BVPS

1.12

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-69.74%

Sector -65.14%

Industry -65.14%

ROA

-64.95%

Sector -65.53%

Industry -65.53%

ROIC

-1,281.86%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

15.85

Sector 2.90

Industry 2.90

Net Debt / EBITDA

6.93

Sector -6.07

Industry -6.07

Net Debt / EBIT

6.92

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.03

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.93

Sector 0.41

Industry 0.41

Liabilities/Assets

0.07

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

21.63%

Sector -

Industry -

Fundamentals RZLT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RZLT Rezolute Inc.	$4.72	-27.94%	0.00%	-5.87	4.09	-69.74%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RZLT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Rezolute

Rezolute Inc.

Average Investor10 user rating

4.0 (1 people)

United States

16 years

Founded: 2010

2011

Time since IPO - 15 years

26

Employees

Rezolute Inc. (United States) is listed on the Nasdaq and has a market capitalization of $478.40 million, with shareholders equity totaling $116.83 million.

The company employs approximately 26 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Rezolute Inc. reported $- in revenue, generating net income of $-81.48 million.

Key financial metrics include a P/E ratio of -5.87, a price-to-book (P/B) ratio of 4.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RZLT.

Market cap

$478.40 million

Net worth

$116.83 million

$116,830,000.00

Assets

$125.46 million

$125,460,000.00

Total Shares Outstanding

104.00 million

104,000,000

Average Daily Trading Volume

$1.77 million

$1,767,448.00

Sector

Health Care

Industry

Biotechnology

RZLT

RZLT revenue and profits

Financial Results RZLT

DRAG THE FRAME TO SEE MORE DATA

RZLT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Rezolute (RZLT) today?

A cotação de Rezolute (RZLT) hoje está em US$ 4.72, com uma variação de -27.05% em relação ao último ano. A cotação de Rezolute (RZLT) iniciou o ano negociando na casa dos US$ 2.36 e hoje está em US$ 4.72. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Rezolute (RZLT) e dados de ações do Ibovespa e mercados internacionais.

Quando Rezolute (RZLT) paga dividendos?

Rezolute (RZLT) não distribuiu dividendos no último ano.

Is Rezolute (RZLT) a good investment?

Atualmente, Rezolute (RZLT) está cotada a US$ 4.72, com um P/L de -5.87, representando um desvio de -304% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -27.05 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -27.05%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Rezolute (RZLT) stock?

Investir em ações de Rezolute (RZLT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Rezolute (RZLT) yield today?

A rentabilidade de Rezolute (RZLT) foi de -3.71% no último mês, -27.05% no último ano e -52.80% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Rezolute (RZLT) hoje, o investimento total seria de US$ 472.00, com base na cotação atual de US$ 4.72.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 344.32
Em 5 anos: US$ 222.78
Em 10 anos: US$ 45.93

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RZLT

Rezolute Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RZLT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RZLT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Rezolute

Rezolute Inc.

United States

16 years

2011

26

PROFIT X PRICE RZLT

Financial Results RZLT

RZLT cash flow

Asset, Revenue and Profit Growth - RZLT

RZLT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions